↓ Skip to main content

Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
4 patents

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
Published in
Journal for Immunotherapy of Cancer, June 2014
DOI 10.1186/2051-1426-2-17
Pubmed ID
Authors

Mizuki Nishino, Maria Gargano, Margaret Suda, Nikhil H Ramaiya, F Stephen Hodi

Abstract

Investigate the impact of the reduction of the number of target lesions on immune-related response assessment in advanced melanoma patients treated with ipilimumab.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 56 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 30%
Other 6 11%
Student > Ph. D. Student 6 11%
Student > Postgraduate 4 7%
Student > Doctoral Student 3 5%
Other 10 18%
Unknown 11 19%
Readers by discipline Count As %
Medicine and Dentistry 30 53%
Agricultural and Biological Sciences 6 11%
Biochemistry, Genetics and Molecular Biology 2 4%
Immunology and Microbiology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 3 5%
Unknown 13 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2023.
All research outputs
#7,363,939
of 25,394,764 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,808
of 3,428 outputs
Outputs of similar age
#66,526
of 243,032 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#6
of 11 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,428 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,032 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.